You are here

Frank D'Amelio

Chief Financial Officer and Executive Vice President, Global Supply and Business Operations

Frank D’Amelio is the Chief Financial Officer and Executive Vice President Business Operations & Global Supply, responsible for finance, supply chain, procurement and real estate. Frank led the acquisition and integration of Medivation, Inc., Anacor Pharmaceuticals, Inc., Hospira Inc., and Wyeth Pharmaceuticals, as well as the spin-off of Pfizer’s animal health business, Zoetis, and the sale of its nutrition business to Nestle and its Capsugel business to KKR.

Before joining the company in September 2007, he was Senior Executive Vice President of Integration and Chief Administrative Officer of Alcatel-Lucent, responsible for the integration of the Alcatel-Lucent merger as well as procurement, real estate, IT and supply chain.

Prior to the merger of Alcatel and Lucent Technologies in 2006, Frank was the Chief Operating Officer of Lucent Technologies. In 2001, he was appointed Executive Vice President and Chief Financial Officer of Lucent, where he helped lead the company through one of the most challenging periods in the telecom industry’s history and returned the company to profitability.

When Lucent was spun off from AT&T in 1996, Frank helped create the new company financially as the CFO of Lucent’s Network Systems Business and was a critical member of the team that met with investors around the world during Lucent’s initial public offering. In 1999, he was appointed the Group President of Lucent’s Switching Solutions Business Unit, where he led Lucent’s multibillion-dollar, global Switching, Access and Application Software businesses.

Born and raised in New Jersey, Frank earned his MBA in Finance from St. John’s University and his bachelor’s degree in Accounting from St. Peter’s University. He started his career in 1979 at Bell Labs, holding a variety of financial, accounting and general management positions, and moved within AT&T, holding a series of positions with increasing responsibility.

In 2005, 2006, 2011, 2012, 2013, 2014, 2016 2017, 2018 and 2019, Frank was ranked among America’s top CFOs by Institutional Investor magazine. In 2002, he was recognized by Treasury & Risk Magazine as one of America’s Top CFOs.

He currently serves on the Board of Directors of: Humana, Inc. and is chair of the Audit Committee; Zoetis, Inc.; and the Independent College Fund of New Jersey.


  • 2002 Bloomberg University Commencement Keynote Speaker
  • 2010 Boy Scouts of America Honoree
  • 2011 St. John’s University Beta Gamma Sigma Inductee
  • 2011 Autism Speaks/Gillen Brewer School Honoree
  • 2012 Distinguished Alumni of St. Peter’s University
  • 2012 National Italian American Foundation Honoree
  • 2013 Calvary Medal Recipient
  • 2014 Rutgers Business School Commencement Keynote Speaker
  • 2014 Columbus Citizens Foundation Honoree